CAMP4 Therapeutics Corporation Common Stock (CAMP) is a publicly traded Healthcare sector company. As of May 21, 2026, CAMP trades at $4.50 with a market cap of $236.78M and a P/E ratio of -1.90. CAMP moved +8.80% today. Year to date, CAMP is -24.87%; over the trailing twelve months it is +101.79%. Its 52-week range spans $1.31 to $12.30. Analyst consensus is strong buy with an average price target of $8.60. Rallies surfaces CAMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent CAMP insider activity includes 5AM Partners VI, LLC bought 2.94M, Polaris Management Co. VII, L.L.C. bought 1.22M, Polaris Management Co. VII, L.L.C. bought 85.47K, Nashat Amir bought 1.22M, and Nashat Amir bought 85.47K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $4.50 |
| Market Cap | $236.78M |
| P/E Ratio | -1.90 |
| EPS | $-2.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.30 |
| 52-Week Low | $1.31 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.93M |
| Net Income | $-86.30M |
| Gross Margin | 0.00% |
6 analysts cover CAMP: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.60.